Table 4.
The stratified analysis of the correlation between TM gene rs3176123 genotype frequency and AKI risk.
| AKI (n = 178) | No AKI (n = 243) | OR (95%CI)∗ | P | |
| Age | ||||
| <60 | ||||
| TT | 46 (47.92%) | 66 (55.00%) | 1.00 | |
| TG | 25 (26.04%) | 36 (30.00%) | 0.99 (0.53–1.88) | .99 |
| GG | 25 (26.04%) | 18 (15.00%) | 1.99 (0.98–4.07) | .08 |
| ≥60 | ||||
| TT | 39 (47.56%) | 67 (54.47%) | 1.00 | |
| TG | 26 (31.71%) | 37 (30.08%) | 1.21 (0.64–2.29) | .68 |
| GG | 17 (20.73%) | 19 (15.45%) | 1.54 (0.72–3.30) | .36 |
| BMI (kg/m2) | ||||
| <26 | ||||
| TT | 44 (49.44%) | 74 (56.92%) | 1.00 | |
| TG | 22 (24.72%) | 36 (27.69%) | 1.03 (0.54–1.97) | .93 |
| GG | 23 (25.84%) | 20 (15.38%) | 1.93 (0.96–3.92) | .10 |
| ≥26 | ||||
| TT | 41 (46.07%) | 59 (52.21%) | 1.00 | |
| TG | 29 (32.58%) | 37 (32.74%) | 1.13 (0.60–2.12) | .83 |
| GG | 19 (21.35%) | 17 (15.04%) | 1.61 (0.75–3.46) | .31 |
| Gender | ||||
| Male | ||||
| TT | 53 (52.48%) | 79 (56.43%) | 1.00 | |
| TG | 31 (30.69%) | 39 (27.86%) | 1.19 (0.67–2.13) | .68 |
| GG | 17 (16.83%) | 22 (15.71%) | 1.15 (0.56–2.37) | .84 |
| Female | ||||
| TT | 32 (41.56%) | 54 (52.43%) | 1.00 | |
| TG | 20 (25.97%) | 34 (33.01%) | 0.99 (0.49–2.01) | .98 |
| GG | 25 (32.47%) | 15 (14.56%) | 2.81 (1.30–6.11) | .01 |
AKI = acute kidney injury, BMI = body mass index, OR = odds ratio, CI = confidence interval.
∗
Adjusted age, BMI, gender.